Results 141 to 150 of about 49,570 (201)

Selective Serotonin Reuptake Inhibitors

Handbook of Experimental Pharmacology, 2018
The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while avoiding adverse effects.
Dee, Lochmann, Tara, Richardson
openaire   +3 more sources

Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis

open access: yesAmerican Journal of Obstetrics and Gynecology, 2019
BACKGROUND: There is a marked increase in the use of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors in the last decade. Many newborns are likely to be exposed during pregnancy and labor.
Reem Masarwa   +2 more
exaly   +2 more sources

The Pharmacogenomics of Selective Serotonin Reuptake Inhibitors

Pharmacogenomics, 2022
Antidepressant medications are frequently used as the first line of treatment for depression. However, their effectiveness is highly variable and influenced by genetic factors. Recently, pharmacogenetic studies, including candidate-gene, genome-wide association studies or polygenic risk scores, have attempted to uncover the genetic architecture of ...
Luis M García-Marín   +5 more
openaire   +4 more sources

Selective Serotonin Reuptake Inhibitors in Pregnancy

Current Medicinal Chemistry, 2012
The use of antidepressant drugs, such as selective serotonin reuptake inhibitors (SSRIs), during pregnancy is rapidly increasing. To date, the effects of SSRI on pregnant women and fetuses are controversial and still a matter of debate. Although a number of studies have shown that these antidepressants are not teratogenic, some of them have reported an
Bellissima, V.   +3 more
openaire   +2 more sources

Selective Serotonin-Reuptake Inhibitors: An Update

Harvard Review of Psychiatry, 1999
Selective serotonin-reuptake inhibitors (SSRIs), including fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram, represent an important advance in the pharmacotherapy of mood and other disorders. They are chemically unrelated to tricyclic, heterocyclic, and other first-generation antidepressants.
P S, Masand, S, Gupta
openaire   +2 more sources

Selective Serotonin Reuptake Inhibitor Exposure

Topics in Companion Animal Medicine, 2013
Many antidepressants inhibit serotonin or norepinephrine reuptake or both to achieve their clinical effect. The selective serotonin reuptake inhibitor class of antidepressants (SSRIs) includes citalopram, escitalopram (active enantiomer of citalopram), fluoxetine, fluvoxamine, paroxetine, and sertraline.
Kevin T, Fitzgerald, Alvin C, Bronstein
openaire   +2 more sources

Clastogenicity of selective serotonin-reuptake inhibitors

Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2004
Selective serotonin-reuptake inhibitors (SSRIs) are used in the treatment of various forms of psychiatric disorders. Preclinical studies in laboratory animals have indicated that SSRIs were not genotoxic, but clear results from in vitro testing of SSRIs in a human cell system are currently scarce.
Gokay, Bozkurt   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy